Gravity Analytica

Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024

XTNT 11.07.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-11-12

Name of Upcoming Event:Xtant Medical Q3 2024 Financial Results

Full Press Release SEC Filings Our XTNT Tweets

About Gravity Analytica

Recent Filings

BELGRADE, MT/ ACCESSWIRE /November 7, 2024/Xtant Medical Holdings, Inc.(NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter endedSeptember 30, 2024, after the close of the financial markets onTuesday, November 12, 2024.

Sean Browne, President and Chief Executive Officer, andScott Neils, Chief Financial Officer, will host a conference call onTuesday, November 12, 2024at4:30 PM ETto review results.

Conference Details:

Conference Date:Tuesday, November 12, 2024Conference Time:4:30 PM ETConference dial-in: 888-999-3182International dial-in: 848-280-6330Passcode:Xtant Medical HoldingsConference Call Name:Xtant MedicalQ3 2024 Financial ResultsWebcast Link:https://www.webcaster4.com/Webcast/Page/3039/51623

Following the live call, a replay will be available on the Company's website,https://xtantmedical.com/, under "Investor Info."

AboutXtant Medical Holdings, Inc.

Xtant Medical'smission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company.Xtant Medical Holdings, Inc.(https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbolsTM and ® denote trademarks and registered trademarks ofXtant Medical Holdings, Inc.or its affiliates, registered as indicated inthe United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact:

Brett MaasManaging PartnerHayden IRbrett@haydenir.com(646) 536-7331

SOURCE:Xtant Medical Holdings, Inc.

press release accesswire.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com